Jump to content

Andreas Clemens

From Wikipedia, the free encyclopedia
Andreas Clemens
Born (1966-05-05) May 5, 1966 (age 58)
NationalityGerman
EducationUniversity of Göttingen
Kiel University
University Hospital Heidelberg
University of Mainz
University of Freiburg
Occupation(s)Medical Director and Head New Medical Brand Incubator & Rare Disease of Novartis
Medical career
ProfessionPhysician
InstitutionsNovartis

Andreas Clemens (born May 5, 1966 in Hildesheim) is a German physician.[1] He is an internist, endocrinologist and diabetologist. His main interest is the investigation and development of drugs in the field of cardiology, endocrinology, ophthalmology and very rare diseases.

Life and work

[edit]

As part of his scientific activities, he has published more than 130 peer-reviewed articles.[2] He has an H-index of 42.[3] He is a member of the European Association for Vision and Eye Research Foundation.[4] He is also an associate editor (editor) at Contemporary Clinical Trials.[5] Furthermore, he is actively involved in teaching at the Albert Ludwigs University of Freiburg, Germany.[6]

References

[edit]
  1. ^ Dabigatranetexilat, ein neuer oraler direkter Thrombininhibitor: Klinische Entwicklung. 2014.
  2. ^ "Andreas Clemens - Global Head Medical Affairs Strategy AID & IRD". ResearchGate. Retrieved 3 April 2023.
  3. ^ "Andreas Clemens, MD, PhD".
  4. ^ "EVER ƒ Members - General Assembly".
  5. ^ "Editorial Board - Contemporary Clinical Trials - Journal - Elsevier".
  6. ^ "Vorlesungsverzeichnis anzeigen - Campus Management - HISinOne".